Patent directory · USPTO A61K / A61P
Patents matching “ONC”
274 pharma patents match "ONC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 274 pharmaceutical patents matching "ONC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11020436
Multipotent and immunocompatible stem cell concentrate
granted -
US 11013767
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10980793
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10973817
Pharmaceutical compounds
granted -
WO 2021052960
COMPOSITION RADIOPHARMACEUTIQUE CONCENTRÉE, STABLE
granted -
US 10953187
Configurable oxygen concentrator and related method
granted -
US 10946080
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 10881689
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10857184
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10842835
Oncolytic vaccinia virus mutants and using same for cancer treatment
granted -
US 10842800
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 2020353106
Stable, concentrated radionuclide complex solutions
granted -
US 10806730
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10765727
Compositions and methods for producing dendritic cells
granted -
US 10738123
Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia
granted -
US 10736919
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10729725
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10730882
2-aminoquinazoline derivatives as P70S6 kinase inhibitors
granted -
US 10716869
Radiolabeled macrocyclic EGFR inhibitor
granted -
US 10675304
Combination immunotherapies for treatment of cancer
granted -
US 10676486
Macrocyclic RIP2 kinase inhibitors
granted -
US 10647785
High concentration chitosan-nucleic acid polyplex compositions
granted -
US 10603351
Engineered synergistic oncolytic viral symbiosis
granted -
US 10596260
Reoviruses having modified sequences
granted